![Richard Gregory](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Gregory
Geen lopende functies
Vermogen: - $ op 31-08-2026
Profiel
Richard James Gregory worked at Genzyme Corp.
from 2003 to 2014, serving as Head-Research & Development from 2011 to 2014.
From 2015 to 2019, worked at ImmunoGen, Inc. as Chief Scientific Officer & Executive VP-Research.
Between 2016 and 2023, was Independent Director at ProMIS Neurosciences, Inc. Held the position of Chief Scientific Officer & Director at Canbridge Pharmaceuticals, Inc. (United States).
Served as Independent Director at Homology Medicines, Inc. From 2020 to 2026, was Independent Non-Executive Director at CANbridge Pharmaceuticals Inc. Education includes a doctorate from the University of Massachusetts conferred in 1986 and an undergraduate degree from Virginia Polytechnic Institute & State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-01-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Eerdere bekende functies van Richard Gregory
| Bedrijven | Functie | Einde |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Directeur/Bestuurslid | 05-08-2026 |
| PROMIS NEUROSCIENCES, INC. | Directeur/Bestuurslid | 27-04-2023 |
| IMMUNOGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 30-08-2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Operates as a biopharmaceutical company which research, development and commercialization of transformative therapies | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Richard Gregory
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
 Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Operates as a biopharmaceutical company which research, development and commercialization of transformative therapies | Health Technology |
CANbridge Pharmaceuticals Inc.
 CANbridge Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
